Language:
Life Sciences – Multi-jurisdictional Guide 2012: Mexico
June 20, 2012
REGULATORY OVERVIEW
1. What is the regulatory framework for the authorisation, pricing and reimbursement of drugs, biologicals and devices (as they are termed in your jurisdiction)?
Legislation
The main regulatory framework in relation to medical products is set out in the following federal laws:
– General Health Law (Ley General de Salud) (LGS).
– Health Law Regulations (Reglamento de Insumos para la
Salud) (RIS).
– Official Mexican Standards (Norma Oficial Mexicana) (NOMs).
Regulatory authorities
The authority responsible for enforcing the regulatory framework in relation to medicines is the Federal Commission for Protection against Sanitary Risk (Sitio Oficial de la Comisión Federal para la Protección contra Riesgos Sanitarios) (COFEPRIS) (see box, The regulatory authority), which is part of the Ministry of Health (Secretaria de Salud)…
READ THE FULL ARTICLE here (Adobe Acrobat Reader required to view this article)
Patent-Law-Articles
- Streghtening the PPH October 16, 2014
- An introduction to the PCT April 28, 2010
- The death of business methods March 22, 2010
- Surge of Patent Application Final Rejections Provides Unique Opportunity for Patent Precent Making March 21, 2012
- Business methods and software-related inventions July 9, 2010
- Congress Amends IP Law January 11, 2011
- Energy reform promises tech transfer and patent boom September 24, 2014
- Data Package Exclusivity (DPE) March 9, 2011